col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


209 Results       Page 1

 [1] 
Wiley: Research and Practice in Thrombosis and Haemostasis
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―26 Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs. no anticoagulation: Final analysis of the OVID randomized trial Riccardo M. Fumagalli, Davide Voci, Behnood Bikdeli, Roland Bingisser, Giuseppe Colucci, Gabor Forgo, et al. (+64)
2 [GO] 2024―Apr―24 High risk subgroups were not identified to benefit from thromboprophylaxis after hospitalization for COVID-19 Lisa Baumann Kreuziger, Taeim Kwon, Raj S. Kasthuri, Lana Wahid, Peter J. Miller, Kimberly Enders, et al. (+4)
3 [GO] 2024―Apr―24 Coagulation and inflammatory response after intramuscular or intradermal mRNA-1273 SARS-CoV-2 vaccine - secondary analysis of a randomized trial Willian J. van Dijk, Margaretha L.M. Prins, Anna H.E. Roukens, Geert V.T. Roozen, Meta Roestenberg, Leo G. Visser, et al. (+2)
4 [GO] 2024―Mar―15 In vitro effect of hydroxyethyl starch on COVID-19 patients associated hypofibrinolytic state Hamdi Rezigue, Michel Hanss, Jean-Stéphane David, Yesim Dargaud, Christophe Nougier
5 [GO] 2024―Mar―01 Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management M. Ge, D. Ladha, J. Lymer, S. Pancic, M. Carrier, G. Le Gal, L.A. Castellucci
6 [GO] 2024―Feb―05 Hematologic Characteristics and Coagulopathy in Pregnancy with COVID-19 S쳮ding The First Wave: A Multicenter Retrospective Cross-Sectional Study Maha Othman, Georgiana Nemeti, Marissa Solow, Gheorghe Cruciat, Daniel Muresan, Mariam Suzana Chaikh Sulaiman, et al. (+3)
7 [GO] 2024―Jan―21 PB1184 Monitoring of Low Molecular Weight Heparin by Thrombodynamics Analyser System (TD T2 T) in Intensive Care Patients with COVID-19 Infection A. Riddell, P. Panagiotidis, A. Drebes, P. Batty, P. Chowdary, G. Getti
8 [GO] 2023―Dec―07 Coagulopathy and adverse outcomes in hospitalized COVID-19: Results from the NOR-Solidarity trial Thor Ueland, Annika E. Michelsen, Anders Aune Tveita, Trine Kåsine, Tuva B. Dahl, Ane-Kristine Finbråten, et al. (+10)
9 [GO] 2023―Nov―14 Breakthrough infections after COVID-19 vaccinations do not elicit platelet hyper-activation and associate with high platelet-lymphocyte and low platelet-neutrophil aggregates Francesca Maiorca, Ludovica Lombardi, Ramona Marrapodi, Davide Pallucci, Annamaria Sabetta, Maria Antonella Zingaropoli, et al. (+17)
10 [GO] 2023―Nov―11 PO06 Blood Count Abnormalities in Coronavirus Infection 2019 (COVID-19) A. Nabila
11 [GO] 2023―Nov―11 PB1070 Small and Large Extracellular Vesicles have Different Tissue Factor Activity in Cancer, Sepsis, and COVID-19 A. Sachetto, S. Archibald, Y. Hisada, A. Rosell, S. Havervall, N. van Es, et al. (+6)
12 [GO] 2023―Nov―11 PB0604 The VWF-ADAMTS13 Axis as Biomarkers of Disease Progression in Severe COVID-19 M. Hinds, M. Bowman, J. Grabell, C. Yeh, P. Gross, A. Fox-Robichaud, et al. (+3)
13 [GO] 2023―Nov―11 PB0601 Identification of a Novel Growth Factor-Enriched Platelet Subpopulation: Potential Implications for COVID-19 A. Asgari, P. Jurasz
14 [GO] 2023―Nov―11 PB0115 Paxlovid Attenuates the Inflammatory and Thrombotic Response in High-Risk Patients with COVID-19 L. Del Carpio-Orantes, S. Hernández-Hernández, A. Aguilar-Silva, A. Rosas-Lozano, S. García-Méndez, J. Sánchez-Díaz, et al. (+2)
15 [GO] 2023―Nov―11 PB0107 The Relationship between Length of Hospital Stay and Anticoagulant Use in Patients with Moderate COVID-19 P. Lasut, R. Cikutra, L. Rotty, H. Haroen, C. Hendratta, R. Rattu, E. Polii
16 [GO] 2023―Nov―11 PB0103 Disturbance of the Hemostatic Balance in Outpatients with Covid-19 M. Iglesias Varela, M. Siracusa, L. Donlo
17 [GO] 2023―Nov―11 PB0093 Antiphospholipid Antibodies in Convalescent Plasma of Donors Recovered from Mild COVID-19 D. Blickstein, M. Izak, T. Filipovich-Rimon, O. Garach-Jehoshua, N. Rahimi-Levene, E. Shinar, et al. (+3)
18 [GO] 2023―Nov―11 PB0091 Fibrin Monomers Positivity During Hospitalization is a Good Predictive Marker of In-Hospital Mortality during COVID-19 D. Smadja, N. Gendron, A. Philippe, J. Diehl, N. Ochat, O. Bory, et al. (+4)
19 [GO] 2023―Nov―11 PB0077 Predictors of Mortality in Hospitalized Patients with COVID-19 M. Chindamo, F. Pozzobon, G. Sardinha, A. Marques, H. Goudar, A. Nunes, et al. (+2)
20 [GO] 2023―Nov―11 PB0069 Risk Factors for Venous Thromboembolism in Patients Hospitalized with COVID-19 M. Chindamo, G. Sardinha, A. Marques, H. Goudar, A. Nunes, P. Carmo, D. Salgado
21 [GO] 2023―Nov―11 PB0051 Persistent Elevation of ɣ’ Fibrinogen in Acute and Convalescent COVID-19 H. Fogarty, G. Gilmore, J. O’Donnell, D. Farrell, J. Tiao, R. Baker
22 [GO] 2023―Nov―11 OC 29.2 The Impact of Pulmonary Embolism on the Long-Term Health Outcomes of COVID-19 C. Visser, J. Berentschot, C. De Jong, M. Antoni, R. Berg-Emons, B. Borst, et al. (+12)
23 [GO] 2023―Nov―11 PO07 Is Covid-19 a Trigger Factor for Thrombotic Complications in Late Pregnancy? V. Popov, B. Mastalier, L. Iliescu, M. Andreescu
24 [GO] 2023―Nov―11 PB0066 Features of Functioning of the ADAMTS-13/vWF Axis in Pregnant Women with Covid-19 and after Infection during Pregnancy N. Gashimova, G. Kristina, V. Bitsadze, L. Pankratyeva, J. Khizroeva, R. Atadzhanova, et al. (+3)
25 [GO] 2023―Nov―11 PB0071 The Impact of COVID-19 and Venovenous ECMO on the Generation and Characteristics of Extracellular Vesicles L. Traby, L. Eischer, M. Kollars, M. Kussmann, N. Buchtele, M. Weiss-Tessbach, et al. (+5)
26 [GO] 2023―Nov―11 OC 29.1 Long-Term Outcomes of COVID-19 Associated Venous Thromboembolism (VTE) W. Ageno, E. Antonucci, D. Poli, E. Bucherini, A. Chistolini, V. Fregoni, et al. (+12)
27 [GO] 2023―Nov―11 PB1338 Thrombotic Thrombocytopenia Syndrome after vaccination against COVID-19 Associated with Antiplatelet Antibodies T. Thiele, M. Esefeld, S. Handtke, J. Rath, L. Schönborn, J. Antovich, et al. (+8)
28 [GO] 2023―Nov―11 PB0056 Predicting VTE and Mortality in COVID-19 by Receiver-Operating Characteristic (ROC) Analysis of Haemostatic and Inflammatory Biomarkers M. Peralta, V. Muczynski, P. Lane, L. Pagala, A. Riddell, S. Bhagani, et al. (+11)
29 [GO] 2023―Nov―11 PB0104 Emergency Mobile and Point of Care Anticoagulation Clinic During (COVID-19) Curfew by Pharmacists in Saudi Arabia F. Alayoubi, A. Al Shaban, I. Elnahal
30 [GO] 2023―Nov―11 PB0600 Circulating Platelet-Derived Extracellular Vesicles are Increased in Severe COVID-19 Disease T. Helin, M. Palviainen, M. Lemponen, K. Maaninka, P. Siljander, L. Joutsi-Korhonen
31 [GO] 2023―Nov―11 PB0096 Cytokines Profile of Severe COVID-19 does not Differ from ICU-Control M. Peralta, B. Newell, V. Muczynski, P. Lane, L. Pagala, D. Hughes, et al. (+12)
32 [GO] 2023―Nov―11 PB0085 Pitfalls of Complications due to Coagulopathy in Patients with Severe COVID-19 during ECMO: Beware of Bleeding Caused by Acquired von Willebrand Syndrome H. Ishikura, Y. Irie, K. Muranishi, J. Maruyama, M. Nakashio, Y. Okura, et al. (+3)
33 [GO] 2023―Nov―11 OC 32.3 Age, Race, D-Dimer, and Modified IMPROVE VTE Score did not Predict Effect of Thromboprophylaxis on Arterial Thromboembolism, Venous Thromboembolism, or Death after COVID-19 Hospitalization L. Baumann Kreuziger, A. Wahed, K. Anstrom, T. Wang, T. Ortel
34 [GO] 2023―Nov―11 OC 29.5 Outcomes of COVID-19 in Persons with Hemophilia: A Propensity ScoreMatched Cohort Study froma US-BasedNational COVIDRegistry A. Sharathkumar, L. Wendt, C. Ortman, E. Chrischilles, C. Takemoto
35 [GO] 2023―Nov―11 PB0054 Impact of Variations in Sex Hormone Levels on the Hypercoagulability and Severity of COVID-19 in Women and Men According to Age. The ROADMAP-COVID-19 Study P. Van Dreden, M. Sabbah, M. Grussé, A. Rousseau, L. Louadj, G. Gerotziafas
36 [GO] 2023―Nov―11 PB0138 COVID-19 Induces miRNA Changes-ACE-2 Related Network: In Silico, Machine Learning and Validation Analysis Z. Wicik, C. Eyileten, A. Nowak, D. Keshwani, M. Marszałek, S. Simões, et al. (+3)
37 [GO] 2023―Nov―11 PB1306 Inhibitor Recurrence Following Immune Tolerance Induction in a Hemophilia A Patient with Inhibitor Post COVID-19 Infection S. Cheng, L. Wang, J. Yu
38 [GO] 2023―Nov―11 PB0072 Thrombin Generation Potential and the Risk of Severe COVID-19 Infection W. van Dijk, K. Föhse, M. Netea, H. van Werkhoven, M. Bonten, M. Grobusch, et al. (+3)
39 [GO] 2023―Nov―11 PB0047 COVID-19 Infection-Associated Platelet and Neutrophil Activation is Blunted by Previous Anti-SARS-CoV-2 Vaccination E. Petito, L. Franco, E. Falcinelli, G. Guglielmini, C. Conti, F. Tondi, et al. (+4)
40 [GO] 2023―Nov―11 PB0613 IL-6 Dosage by ELISA Tests in Patients after COVID-19 Infection: Significant Correlation between Length of Hospitalization and Permanently Altered Levels of Interleukin-6 A. Prezotti, D. Campos da Silva, H. Vitória, A. Zetum, H. Rosa, V. Ventorim, et al. (+14)
41 [GO] 2023―Nov―11 PB0049 Thromboprophylaxis with Enoxaparin for Symptomatic COVID-19 Managed in the Ambulatory Setting: Pooled Analysis of the OVID and ETHIC Trials S. Barco, S. Virdone, F. Cools, R. Fumagalli, A. Götschi, G. Kayani, et al. (+5)
42 [GO] 2023―Nov―11 PB0100 Anticoagulation in Hospitalized COVID-19 Obese Patients and Venous Thromboembolism (VTE) in Salvador - Brazil A. Rocha, L. Zanatta, J. Gomes, J. De Oliveira, R. Ferreira, L. Ritt
43 [GO] 2023―Nov―11 PB0022 Impact of COVID-19 on Thromboembolic Events and Mortality among Patients with Non-Valvular Atrial Fibrillation Receiving Oral Anticoagulants I. Hernandez, A. Dhamane, X. Liu, N. Atreja, S. Han, Q. Zhang, et al. (+3)
44 [GO] 2023―Nov―11 PB0282 Evaluation of Plasma Coagulative and Fibrinolytic Function in Critically Ill Children with COVID-19 or MIS-C An Analysis of the COVAC-TP Trial A. Sellers, S. Bruzek, E. Amankwah, V. Ignjatovic, M. Betensky, N. Goldenberg, A. Sochet
45 [GO] 2023―Nov―11 PB0469 Frequency of INR Monitoring and Their Impact on INR Control during the COVID-19 Pandemic T. Elling, N. Veeger, D. Hardeman, A. Kruit, J. Pouwels, V. Tichelaar, K. Meijer
46 [GO] 2023―Nov―11 PB0074 Hyper-Immunoglobulin-CovImmuneTM, Provides a Broader Coverage Against Diverse SARS-CoV-2 Variants Relevant to the COVID-19 Pandemic L. Rozen, C. Maoudis, J. Foster, S. Turville, T. Kelleher, S. Mahler, H. Nair
47 [GO] 2023―Nov―11 PB1225 Acquired Haemophilia in the COVID-19 Pandemic Era - Does Vaccination or Infection Increase its Risk and Influence Outcomes? A. Chia, M. Cheong, W. Wong, C. Tan, H. Kaur, S. Tien, et al. (+3)
48 [GO] 2023―Nov―11 PB0080 The Effect of COVID-19 Pandemic in Haemophilia Patients in Argentina M. Martinez, M. Williams, D. Neme, S. Borchichi, G. Sliba, H. Caferri, et al. (+14)
49 [GO] 2023―Nov―11 PB0326 Incidence of Thrombotic Thrombocytopenic Purpura and Other Suspected Thrombotic Microangiopathies during the COVID-19 Pandemic Period 2020-2021 in Q C. Merlen, E. Pépin, S. Thouzeau, G. Rivard, S. Troyanov, A. Bonnefoy
50 [GO] 2023―Nov―11 PB0774 The Role of Immunothrombosis in Acute Coronary Syndrome (ACS) Patients during COVID-19 Pandemic: Analysis during a 2 Year Follow-Up P. Gomez Rosas, M. Marchetti, L. Pescetelli, E. Sanga, L. Russo, S. Gamba, et al. (+9)
51 [GO] 2023―Nov―11 PO05 Challenges with Warfarin Management in COVID-19 Patients C. Choo, K. Kng, K. Ong, E. Goh, B. Fan, N. Pandit
52 [GO] 2023―Nov―11 PB0101 Comparison of Padua Prediction Score and IMPROVE VTE Risk Score for Venous Thromboembolism at Admission to Assess Hypercoagulation in COVID-19 Patients P. Lasut, A. Hukom, V. Irawan, J. Arifputra, L. Rotty, H. Haroen, C. Hendratta
53 [GO] 2023―Nov―11 PB0094 Antiphospholipid Antibodies in Severe and Critically ill COVID-19 Patients J. Khizroeva, A. Makatsariya, V. Bitsadze, M. Tretyakova, A. Solopova, A. Vorobev, et al. (+8)
54 [GO] 2023―Nov―11 PB0097 Intracellular Nuclear Proteins Histone H3 and HMGB1 are Predictive Markers of Disease Severity and Prognosis of COVID-19 Patients K. Hayashi, D. Koyama, Y. Hamazak, T. Kamiyama, S. Yamada, Y. Tanino, et al. (+2)
55 [GO] 2023―Nov―11 PB0083 Efficacy and Safety of Thromboprophylaxis in Covid-19 Patients W. Maneechot, R. Lamool
56 [GO] 2023―Nov―11 PB0081 von Willebrand Factor and Myeloperoxidase as Laboratory Predictive Markers of In-Hospital Survival in Severe COVID-19 Patients A. Makatsariya, V. Bitsadze, J. Khizroeva, L. Pankratyeva, J. Gris, I. Elalamy, et al. (+10)
57 [GO] 2023―Nov―11 PB0059 Thrombomodulin Resistance as a Novel Pathway Involved in the Hypercoagulable State of COVID-19 Patients A. Montaño, A. Marco, F. López Jaime, I. Fernández-Bello, P. Marco Vera
58 [GO] 2023―Nov―11 PB0055 Influence of Argatroban on Fibrinolysis ex-vivo in Blood Samples of Healthy Volunteers and in-vivo in Critically ill COVID-19 Patients M. Bachler, A. Tobiasch, J. Bösch, K. Pezzi, D. Niederbrunner, R. Kammerlander, et al. (+3)
59 [GO] 2023―Nov―11 PB0046 Increased Platelet Activation Demonstrated by Elevated CD36 and P-Selectin Expression in 1-year Post Recovered COVID-19 Patients S. Wang, K. Chee, S. Wong, G. Tan, H. Ang, B. Leung, et al. (+9)
60 [GO] 2023―Nov―11 OC 55.1 Balance between Neutrophil Extracellular Trap Formation and DNase Activity in COVID-19 Patients G. Garcia, S. Labrouche-Colomer, A. Duvignaud, E. Clequin, C. Dussiau, D. Tregouet, et al. (+6)
61 [GO] 2023―Nov―11 OC 05.4 Defective Nitric Oxide Production and Increased Reactive Oxygen Species Generation by Platelets from COVID-19 Patients E. Petito, G. Guglielmini, E. De Robertis, E. Giglio, C. Becattini, E. Falcinelli, et al. (+7)
62 [GO] 2023―Nov―11 PB0082 VTE Incidence and Risk Factors among Hospitalized COVID-19 Patients in Salvador -Brazil A. Rocha, R. Ferreira, L. Zanatta, J. De Oliveira, J. Gomes, L. Ritt
63 [GO] 2023―Nov―11 PB0079 Severity of Pulmonary Embolism among Hospitalized COVID-19 Patients in Salvador-Brazil A. Rocha, J. De Oliveira, L. Zanatta, R. Ferreira, J. Gomes, L. Ritt
64 [GO] 2023―Nov―11 PB0073 A Retrospective Study of Two Anticoagulation Therapies In Critically Ill Covid-19 Patients Prior to Vaccination Era R. Costa-Filho, A. Oliveira, E. Furtado, F. Saddy, R. de Souza, M. Azevedo, et al. (+4)
65 [GO] 2023―Nov―11 PB0602 Plasma NET Markers Kinetics in COVID-19 Patients Receiving Immunomodulatory Treatments G. Garcia, A. Dewitte, S. Labrouche-Colomer, C. Mouton, C. Delassasseigne, F. Ménard, et al. (+8)
66 [GO] 2023―Nov―11 PB0065 Targeting the Endothelium when Treating Convalescent COVID-19 Patients, the Effect on Serum Biomarkers, and Post-COVID Functional Status. Midterm Results of a Randomized, Placebo-Controlled Trial A. Gonzalez Ochoa, A. Hernandez, J. Fareed
67 [GO] 2023―Nov―11 PB0063 IMPROVE-DD Score among Hospitalized COVID-19 Patients to Predict Post-Discharge VTE Prophylaxis A. Rocha, R. Ferreira, L. Zanatta, J. Gomes, J. De Oliveira, L. Ritt
68 [GO] 2023―Nov―11 PB0089 Anticoagulants after COVID-19 Pneumonia for Patients with Low Thrombotic Risk T. Pertseva, L. Konopkina, N. Habshydze, L. Botvinikova, O. Myronenko
69 [GO] 2023―Nov―11 PB0067 Prognostic Value of the ISTH DIC Scoring System in Prediction of 28-Day Mortality in Hospitalized COVID-19 Pneumonia Patients T. Thamgrang, P. Silpsamrit, R. Lamool, K. Prayongratana
70 [GO] 2023―Nov―11 OC 29.3 CD147 Plasma Levels in Hospitalised Patients with Covid-19 Pneumonia Predict Illness Severity and In-Hospital Mortality D. Smadja, A. Philippe, E. Campos, R. Oliveira, C. Mccabe, L. Zhao
71 [GO] 2023―Nov―11 OC 05.5 Hemostatic Biomarkers in Long-Covid Syndrome: A Cross-Sectional Study of 1,310 Covid-19 Survivors C. Ambaglio, S. Benatti, C. Tartari, C. Giaccherini, L. Russo, S. Gamba, et al. (+10)
72 [GO] 2023―Nov―11 PB0064 Involvement of Platelet Activation in Long COVID-19 Syndrome M. Brambilla, M. Conti, A. Becchetti, P. Canzano, P. Agostoni, M. Pengo, et al. (+6)
73 [GO] 2023―Nov―11 PB0050 Heparin Concentrations in Pediatric Patients with Paediatric Inflammatory Multisystem Syndrome Associated with COVID-19. The Measurement Importance in the Inflammatory State M. Nuñez Toscano, L. Valderrama Orenday, N. Lopez Santiago, R. Paredes Aguilera, M. Gonzalez Pedroza
74 [GO] 2023―Nov―11 PB1100 Effects of COVID-19 Vaccination on Pro-Coagulant State of a Protein S-Deficient Pediatric Patient: New Hope for Treatment of the Deficiency D. Polania-Villanueva, M. Kumar, L. Thangada, J. Garai, J. Zabaleta, R. Majumder
75 [GO] 2023―Nov―11 PB0266 Effect of COVID-19 Vaccine or Infection on Pediatric Patients with Current or Prior Immune Thrombocytopenia W. Chue, N. Binte Abdul Kadir, J. Lam
76 [GO] 2023―Nov―11 OC 76.5 Head-to-head Comparison of Four COVID-19 Vaccines on Platelet Activation, Coagulation and Inflammation. the TREASURE Study M. Brambilla, P. Della Valle, A. Becchetti, M. Conti, P. Canzano, M. Alberti, et al. (+6)
77 [GO] 2023―Nov―11 OC 05.3 Incidence and Risk Factors for Venous Thromboembolism in Hospitalized Patients Across Three Major COVID-19 Variants in an Asian Cohort S. Lee, W. Teo, C. Lim, W. Jen, C. Lee, E. Yap, Y. Chee
78 [GO] 2023―Nov―11 OC 22.2 Endothelial Activation and Von Willebrand Factor Role in COVID-19- Associated Coagulopathy R. Aiolfi, H. Deguchi, J. Fernández, J. Ahmed, M. Hauer-Jensen, S. Kanaji, et al. (+3)
79 [GO] 2023―Nov―11 OC 01.4 Prevalence of Chronic Thromboembolic Pulmonary Hypertension and Evaluation of Thrombus Resolution in COVID-19-Associated Pulmonary Embolism Survivors C. De Jong, C. Visser, M. Kruip, E. Klok
80 [GO] 2023―Nov―11 LB 01.5 Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial C. Lowenstein, S. Solomon, A. Bhatt, A. Peikert, O. Vardeny, M. Kosiborod, et al. (+14)
81 [GO] 2023―Nov―11 PB0612 COVID-19: Predictive Value of Methemoglobinemia H. Hadjer, B. Mouna Rajaa, B. Bouchra, B. Adel, G. Faiza, M. Najdette, et al. (+2)
82 [GO] 2023―Nov―11 PB0052 Heparin Type & Clinical Outcomes in Hospitalized, Non-Critically Ill Patients with COVID-19: Secondary Analysis of an International Multi-Platform RCT Q. Tays, B. Houston, W. Teng, R. Balshaw, P. Lawler, S. Lother, et al. (+13)
83 [GO] 2023―Nov―11 OC 29.4 Impact of Symptom Duration on Clinical Outcomes in Hospitalized, Non-Critically Ill Patients with COVID-19; Secondary Analysis of an International Multi-Platform RCT Q. Tays, W. Teng, B. Houston, R. Balshaw, P. Lawler, S. Lother, et al. (+13)
84 [GO] 2023―Nov―11 OC 05.2 Impact of Heparin on Disease State Transition in Hospitalized, Non-Critically Ill Patients with COVID-19; Secondary Analysis of an International Multi-Platform RCT Q. Tays, B. Houston, W. Teng, R. Balshaw, P. Lawler, S. Lother, et al. (+13)
85 [GO] 2023―Nov―11 PB0114 Human Immunodeficiency Virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2): Dangerous Liaisons? S. Louw, B. Jacobson, E. Mayne
86 [GO] 2023―Nov―11 PB0768 Mouse Strain Specific Response to a Murine Coronavirus Respiratory Infection P. Gibler, L. Boccuni, M. Salzmann, J. Pointner, R. Plasenzotti, J. Wojta, et al. (+2)
87 [GO] 2023―Nov―11 PB0076 Platelet Activation and Cytokine Release of Interleukin-8 and IP-10 after ChAdOx1 nCoV-19 Coronavirus Vaccine Injection Y. Wu, C. Shen, T. Wang, C. Liu
88 [GO] 2023―Nov―11 OC 22.5 Effect of Angiostatin and its Neutralization on Cellular Infection by SARS-CoV and SARS-CoV-2 A. Franczak, M. Joyce, M. Saito, L. Tyrrell, P. Jurasz
89 [GO] 2023―Nov―11 PB0772 Platelet-B Cell Interactions Modulate the Antibody Response to Adenoviral and mRNA Vaccines against SARS-CoV-2 D. Pallucci, L. Lombardi, F. Maiorca, R. Marrapodi, A. Sabetta, N. Scafa, et al. (+9)
90 [GO] 2023―Nov―11 PB0084 Incidences of Adverse Effects of Vaccination against SARS-CoV-2 in Patients with Congenital Coagulopathies B. Diaz Jordan
91 [GO] 2023―Nov―11 OC 22.1 Proteome and Phosphoproteome Analyses of SARS-CoV-2 Infected Humanized ACE2 Mice Platelets Revealed Reprogramming of Platelets from Early Hyperreactive to Late Antiviral Phenotypes S. Subramaniam, R. Hekman, A. Jayaraman, D. Kenney, A. Kateri O’Connell, P. Montanaro, et al. (+8)
92 [GO] 2023―Nov―11 PB0087 Use of Viscoelastic Tests in the Intensive Care Unit for the Evaluation of Haemostasis in SARS-COV-2 Infection T. Sevivas, I. Santos, J. Alves, J. Luzio, J. Pego, F. Caramelo, et al. (+2)
93 [GO] 2023―Nov―11 PB0599 Dysregulation of Annexin A2 System Triggered by Acute SARS-CoV-2 Infection in Human ACE2 Transgenic Mice A. Drelich, P. Saenkham-Huntsinger, B. Judy, P. Huang, P. Bi-Hung, T. Ksiazek, C. Tseng
94 [GO] 2023―Nov―11 PB0062 Extracellular Vesicles as Markers of Inflammation and Hypercoagulability during the First Month of Sars-COV-2 Infection in Outpatients and Hospitalized Patients B. Barion, T. Rocha, P. Villaça, H. Yeh Li, B. Mazetto, E. Okazaki, et al. (+4)
95 [GO] 2023―Nov―11 PB0057 SARS-CoV-2 Infection Results in Upregulation of PAI-1 and Neuroserpin in the Lungs, and an Increase in Fibrinolysis Inhibitors Associated with Disease Severity K. Toomer, G. Gerber, Y. Zhang, L. Daou, M. Tushek, J. Hooper, I. Francischetti
96 [GO] 2023―Nov―11 OC 76.4 Elevation of Antiphospholipid Antibody Titers Following Vaccination with SARS-CoV-2 mRNA in Patients with Antiphospholipid Syndrome and/or Systemic Lupus Erythematosus M. Yasuda, Y. Fujieda, K. Sakiyama, M. Tada, H. Moriya, J. Wei, et al. (+8)
97 [GO] 2023―Nov―11 PB0060 Thrombosis in Greek Children Before and After SARS-CoV-2 Outbreak: A Single Centre Experience A. Dettoraki, L. Ioannidou, A. Michalopoulou, N. Papageorgiou, S. Saslis, I. Stamati, et al. (+4)
98 [GO] 2023―Nov―11 OC 22.4 SARS-CoV-2 Protein ORF3a Promotes Release of Procoagulant Tissue Factor-Positive Extracellular Vesicles S. Ansari, J. Ludington, K. Enjyoji, P. Anderson, G. Oliveira Junior, I. Ghiran, et al. (+3)
99 [GO] 2023―Nov―11 OC 22.3 Monocytes and Macrophages Promote Increased Tissue Factor/Factor VIIa-Dependent Procoagulant Activity in Response to the SARS-CoV-2 Spike Protein J. Harte, C. Coleman-Vaughan, J. McCarthy, M. Crowley, V. Mykytiv
100 [GO] 2023―Nov―11 PB0607 Evaluation of Proinflammatory and Haemostasis Markers after BNT162b2 SARS-CoV-2 Vaccination I. Ivanko, I. Celap, S. Margetic, D. Marijančević, A. Vahtarić, J. Josipovic, P. Gaćina
101 [GO] 2023―Nov―11 PB0349 Anti-PF4-Antibodies in Patients Suspected of Vaccine-Induced Immune Thrombotic Thrombocytopenia After SARS-CoV-2 Vaccination G. Uzun, K. Althaus, S. Hammer, T. Bakchoul
102 [GO] 2023―Nov―11 OC 76.3 SARS-CoV-2 Vaccination and Risk of Venous Thrombosis - Case Control Study on Routine Care Data from Dutch General Practitioners W. van Dijk, S. Hugten, F. Rosendaal, A. Van Hylckama Vlieg
103 [GO] 2023―Nov―11 PB0088 Alterations in Thrombin Generation after SARS-CoV-2 Vaccination and the Relation with Inflammation W. van Dijk, M. Prins, A. van Hylckama Vlieg, L. Visser, F. Rosendaal
104 [GO] 2023―Nov―11 PO04 SARS-CoV-2 Vaccinations and Risk of Venous Thrombosis - Case Control Study W. van Dijk, A. Kant, F. Rosendaal, A. van Hylckama Vlieg
105 [GO] 2023―Nov―11 OC 55.3 Inflammasome Activation in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) After Immunization with Adenovirus-Based SARS-CoV-2 Vaccines R. Martins-Gonçalves, D.P. Mendes-De-Almeida, C.Q. Sacramento, S. Vicente Rozini, J. Bokel, G. Vitiello Teixeira, et al. (+9)
106 [GO] 2023―Nov―11 PB0352 Non-Pathogenic Anti-PF4 Antibodies after SARS-CoV-2 Vaccines: Long Term Follow-Up G. Uzun, K. Althaus, T. Bakchoul
107 [GO] 2023―Nov―11 PB0800 Infection with Ancestral SARS-CoV-2 versus Variants of Concern Delta and Omicron Differentially Alter the Megakaryocyte Transcriptome M. Sowa, T. Michael, F. Schlamp, M. Samanovic, M. Mulligan, J. Berger, T. Barrett
108 [GO] 2023―Nov―11 PB0086 Prospective Assessment of Thrombomodulin Resistance in Oncological Patients and Healthy Subjects Following Vaccination Against Sars-Cov-2 with the mRNAVaccine. The Roadmap-COVID-19-Vaccin Study P. Van Dreden, J. Gligorov, E. Terpos, M. Jamelot, M. Grussé, I. Elalamy, et al. (+4)
109 [GO] 2023―Nov―11 PB0362 Atypical Hemolytic Uremic Syndrome after SARS-CoV2 Infection with C3 p.I1157 T Mutation T. Matsumoto, H. Wada, M. Ikejiri, K. Ino, K. Suzuki, Y. Sugimoto, I. Tawara
110 [GO] 2023―Nov―11 OC 05.1 Impact of Low Molecular Weight Heparin (LMWH) on SARS-CoV2 Infection: HEPARIN-SARS-CoV2 Clinical Trial R. Otero-Candelera, D. González-Vergara, I. Caparrós-Miranda, E. Mendoza-Zambrano, A. García-Ortega, C. Rodriguez-Matute, et al. (+3)
111 [GO] 2023―Nov―11 PB0512 Impact of the Pandemic on Anticoagulant Therapy - Preliminary Study F. Pires, A. Freixo, C. Câmara, I. Amado, R. Capelo, Á. Beleza
112 [GO] 2023―Nov―11 PB1159 Critical Values in Hemostasis Laboratory. Analysis in a 3 Years Period Including Pandemics M. Martinuzzo, M. López, C. Berger, L. Barrera
113 [GO] 2023―Nov―11 PB0758 Comparative study of Immunothrombotic Biomarkers in Patients with Rheumatologic Diseases and Long COVID Y. Ambriz-Murilo, A. Méndez, N. García-Larragoiti, S. López-Castañeda, P. Guzmán-cancino, M. Trujillo, et al. (+2)
114 [GO] 2023―Nov―11 PB0090 D-Dimer as an Indirect Marker of Microthrombi in Patients with Long COVID L. Del Carpio-Orantes, A. Rosas-Lozano, A. Aguilar-Silva, S. García-Méndez, J. Sánchez-Díaz, S. Hernández-Hernández, et al. (+2)
115 [GO] 2023―Nov―11 PB0068 Pulmonary Sequelae in Long COVID are not Associated with the Carriage of Prothrombotic Genetic Variants G. de Larrañaga, P. Rossi, F. Trullas, V. Brichetti, S. Perés, F. Aranda, et al. (+6)
116 [GO] 2023―Nov―11 PB0061 von Willebrand Factor as a Biomarker of Endothelial Activation/Injury in Long COVID Patients Like What Reported in HIV Patients under Treatment G. de Larrañaga, S. Perés, F. Aranda, V. Brichetti, J. Tejada, J. Vázquez, et al. (+7)
117 [GO] 2023―Nov―03 COVID-19. Comparison of D-dimer levels measured with three commercial platforms Erica Scalambrino, Marigrazia Clerici, Sara Scardo, Marco Capecchi, Claudia Della Noce, Sophie Testa, et al. (+2)
118 [GO] 2023―Nov―02 Therapeutic-dose heparin in preventing COVID-19-associated acute kidney injury: What about bleeding risk? Chia Siang Kow, Kaeshaelya Thiruchelvam
119 [GO] 2023―Nov―01 Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: A case series Daniela P. Mendes-de-Almeida, Patrícia Mouta Nunes de Oliveira, Victor Bertollo Gomes Porto, Renata Saraiva Pedro, Paulo Roberto Gomes Takey, Letícia Kegele Lignani, et al. (+7)
120 [GO] 2023―Oct―11 Venous Thromboembolism in an Asian COVID-19 Cohort Across Three Infection Waves - A Retrospective Observational Study Shir Ying Lee, Winnie Z.Y. Teo, Cheryl XQ. Lim, Chun Tsu Lee, Wei-Ying Jen, Sanjay de Mel, et al. (+2)
121 [GO] 2023―Sep―29 Long-term risk of venous thromboembolism after COVID-19 mainly related to ICU-stay based on findings of a self-controlled case series study. Ioannis Katsoularis
122 [GO] 2023―Sep―28 Platelets of COVID-19 patients display mitochondrial dysfunction, oxidative stress and energy metabolism failure compatible with cell death. Valentine Léopold, Osoul Chouchane, Joe M. Butler, Alex R. Schuurman, Erik H.A. Michels, Justin de Brabander, et al. (+14)
123 [GO] 2023―Sep―20 COVID-19-associated Venous Thromboembolism: Risk of Recurrence and Major Bleeding Pablo DEMELO-RODRIGUEZ, Rubén ALONSO-BEATO, Luis JARA-PALOMARES, Francisco GALEANO-VALLE, Alessandra BURA-RIVIERE, Adriana VISONÀ, et al. (+4)
124 [GO] 2023―Sep―16 Effects of Inflammation on Thrombosis and Outcomes in COVID-19: Secondary Analysis of the ATTACC/ACTIV-4a Trial Amanda T. Walborn, Anna Heath, Matthew D. Neal, Ryan Zarychanski, Lucy Z. Kornblith, Prof Beverley J. Hunt, et al. (+4)
125 [GO] 2023―Aug―30 Citrullination of α2-antiplasmin is unlikely to contribute to enhanced plasmin generation in COVID-19 pathophysiology Kadri Kangro, Robert A. Campbell, Ronak Tilvawala, Matthew J. Flick, Alisa S. Wolberg
126 [GO] 2023―Aug―30 HTRS2023.O8B.2 Proteome and phosphoproteome analyses of SARS-CoV-2 infected humanized ACE2 mice platelets reveal early hyperactive and late antiviral phenotypes Saravanan Subramaniam, Ryan Matthew Hekman, Archana Jayaraman, Aoife Kateri O’Connell, Paige Montanaro, Devin Kenney, et al. (+8)
127 [GO] 2023―Aug―09 Plasma tPA is associated with lipoprotein(a) and clinical outcomes in hospitalized COVID-19 Patients Ziyu Zhang, Wen Dai, Wen Zhu, Maya Rodriguez, Hayley Lund, Yuhe Xia, et al. (+15)
128 [GO] 2023―Aug―09 Effect of Therapeutic-Dose Heparin on Severe Acute Kidney Injury and Death in Non-Critically Ill Patients Hospitalized for COVID-19: A Pre-Specified Secondary Analysis of the ACTIV4a and ATTACC randomized trial Nathaniel R. Smilowitz, Erinn M. Hade, Lucy Z. Kornblith, Lana A. Castellucci, Mary Cushman, Michael Farkouh, et al. (+15)
129 [GO] 2023―Jul―13 Exploring heterogeneity in reported venous thromboembolism risk in COVID-19 and comparison to other viral pneumonias: a systematic review and meta-regression B.S. Bhoelan, C. Codreanu, Y.I.G.V. Tichelaar, J.F. Borjas Howard, K. Meijer
130 [GO] 2023―Jul―01 Thrombotic and hemorrhagic complications of COVID-19 for adults hospitalized in high-income countries compared to low- and middle-income countries in an international registry. Matthew J. Griffee, Patricia T. Bozza, Luis Felipe Reyes, Devin P. Eddington, Dorothea Rosenberger, Laura Merson, et al. (+6)
131 [GO] 2023―Jun―21 Pulmonary embolism and deep venous thrombosis after COVID-19: long-term risk in a population-based cohort study Helen Sjoland, Martin Lindgren, Triantafyllia Toska, Per-Olof Hansson, Katarina Glise Sandblad, Christian Alex, et al. (+6)
132 [GO] 2023―Jun―21 Podoplanin and CLEC-2 levels in patients with COVID-19 Ivanio Teixeira Borba-Junior, Franciele Lima, Davi Sidarta Vitoria Rodrigues Oliveira, Carla Roberta Peachazepi Moraes, Joyce M. Annichino-Bizzacchi, Bruna Bombassaro, et al. (+7)
133 [GO] 2023―May―18 Von Willebrand factor and the thrombophilia of severe COVID-19: in situ evidence from autopsies Jana van den Berg, Jasmin D. Haslbauer, Anna K. Stalder, Anna Romanens, Kirsten D. Mertz, Jan-Dirk Studt, et al. (+4)
134 [GO] 2023―Apr―26 VENOUS THROMBOEMBOLISM SECONDARY TO HOSPITALIZATION FOR COVID-19 DISEASE: PATIENT MANAGEMENT AND LONG-TERM OUTCOMES Walter Ageno, Emilia Antonucci, Daniela Poli, Eugenio Bucherini, Antonio Chistolini, Vittorio Fregoni, et al. (+12)
135 [GO] 2023―Mar―15 SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms Oscar Borsani, Virginia V. Ferretti, Ilaria C. Casetti, Daniele Vanni, Chiara Trotti, Daniela Pietra, et al. (+3)
136 [GO] 2023―Mar―08 Thrombosis and bleeding in COVID-19 patients requiring extracorporeal membrane oxygenation: A systematic review and meta-analysis Yu Jin, Yang Zhang, Jinping Liu, Zhou Zhou
137 [GO] 2023―Feb―15 COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic Hanny Al-Samkari
138 [GO] 2023―Feb―14 Endothelial cell activation, Weibel-Palade body secretion and enhanced angiogenesis in severe COVID-19 Ellie Karampini, Helen Fogarty, Stephanie Elliott, Hannah Morrin, Colm Bergin, Jamie M. O’Sullivan, et al. (+11)
139 [GO] 2023―Feb―08 Venous or Arterial Thrombosis in COVID-19 Cases in the North Carolina COVID-19 Community Research Partnership (NC-CCRP) Michael E. DeWitt, David M. Herrington, John W. Sanders
140 [GO] 2023―Feb―06 Convalescent Plasma Therapy for COVID-19 in Ambulatory vs Hospitalized Patients: Efficacy and Risk of Thromboembolism Pei Ye Li, Philip Yu, Allen Li, Faran Khalid, Marissa Liselle Laureano, Mark Andrew Crowther
141 [GO] 2023―Jan―30 SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people Lamya Garabet, Anna Eriksson, Eirik Tjønnfjord, Xue-Yan Cui, Magnus Kringstad Olsen, Hege Karine Jacobsen, et al. (+12)
142 [GO] 2023―Jan―28 Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet function Marina Rieder, Niklas Baldus, Daniela Stallmann, Maren Jeserich, Isabella Goller, Luisa Wirth, et al. (+10)
143 [GO] 2023―Jan―14 No changes in haemostasis after COVID-19-heterologous vaccination schedule: a sub analysis of the phase 2 CombiVacS study Nora V. Butta, Elena G. Arias-Salgado, Elena Monzón Manzano, Paula Acuña, María Teresa Álvarez Román, Antonio Buño-Soto, et al. (+11)
144 [GO] 2023―Jan―14 Sex Differences in D-Dimer and Critical Illness in COVID-19 Patients: A Systematic Review and Meta-analysis Olivia Saville, Malak Elbatarny, Yousra Tera, Yan Deng, Maha Othman
145 [GO] 2023―Jan―11 Effects of convalescent plasma infusion on the ADAMTS13-von Willebrand factor axis and endothelial integrity in patients with severe and critical COVID-19 Quan Zhang, Zhan Ye, Paul McGowan, Christopher Jurief, Andrew Ly, Antonia Bignotti, et al. (+2)
146 [GO] 2023―Jan―10 Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patients Philip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, Chee Wee Tan, Anoop Enjeti, Vivien Mun Yee Chen, et al. (+8)
147 [GO] 2023―Jan―07 Outcomes associated with antiphospholipid antibodies in COVID-19: a prospective cohort study Arielle Mendel, Marvin J. Fritzler, Yvan St-Pierre, Joyce Rauch, Sasha Bernatsky, Évelyne Vinet
148 [GO] 2022―Nov―16 Pulmonary embolism-related mortality during the COVID -19 pandemic: Data from the United States Karlyn A. Martin, Katharine Harrington, Xiaoning Huang, Sadiya S. Khan
149 [GO] 2022―Nov―16 Cerebral vein thrombosis after ChAdOx1 nCov-19 vaccination: Long-term outcome of four patients Deepa J. Arachchillage, Christina Crossette-Thambiah, Namir Asmar, Saipriya Ramji, Mike Laffan
150 [GO] 2022―Oct―31 Modulation of thromboinflammation in hospitalized COVID-19 patients with aprotinin, low molecular weight heparin, and anakinra: The DAWn-Antico study Matthias M. Engelen, Quentin Van Thillo, Albrecht Betrains, Iwein Gyselinck, Caroline P. Martens, Valérie Spalart, et al. (+50)
151 [GO] 2022―Jul―21 Biomarker derived risk scores predict venous thromboembolism and major bleeding among patients with COVID-19 Scott C. Woller, Scott M. Stevens, Joseph R. Bledsoe, Masarret Fazili, James F. Lloyd, Greg L. Snow, Benjamin D. Horne
152 [GO] 2022―Jun―17 No association of low-dose aspirin with severe COVID-19 in France: A cohort of 31.1 million people without cardiovascular disease Jérémie Botton, Laura Semenzato, Julie Dupouy, Rosemary Dray-Spira, Alain Weill, Olivier Saint-Lary, Mahmoud Zureik
153 [GO] 2022―May―30 To escalate thromboprophylacic heparin intensity in COVID-19 or not? That is still the question Behnood Bikdeli
154 [GO] 2022―May―26 D-dimer testing in clinical practice in the era of COVID-19 Claire Auditeau, Lina Khider, Benjamin Planquette, Olivier Sanchez, David M. Smadja, Nicolas Gendron
155 [GO] 2022―May―18 Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: The Swiss COVID-HEP randomized clinical trial Marc Blondon, Sara Cereghetti, Jérôme Pugin, Christophe Marti, Pauline Darbellay Farhoumand, Jean-Luc Reny, et al. (+13)
156 [GO] 2022―May―02 Platelet-leukocyte interactions in COVID-19: Contributions to hypercoagulability, inflammation, and disease severity Eugenio D. Hottz, Patrícia T. Bozza
157 [GO] 2022―Apr―20 Risk of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination prior to the recognition of vaccine-induced thrombocytopenia and thrombosis: A self-controlled case series study in England Hannah Higgins, Nick Andrews, Julia Stowe, Gayatri Amirthalingam, Mary Ramsay, Gurpreet Bahra, et al. (+17)
158 [GO] 2022―Apr―15 Coagulation factor inhibitors in COVID-19: From SARS-CoV-2 vaccination to infection Jeremy W. Jacobs, Brian D. Adkins, Shannon C. Walker, Garrett S. Booth, Allison P. Wheeler
159 [GO] 2022―Apr―05 Thromboprophylaxis in COVID-19: Weight and severity adjusted intensified dosing Matthias M. Engelen, Christophe Vandenbriele, Valérie Spalart, Caroline P. Martens, Bert Vandenberk, Pieter Sinonquel, et al. (+14)
160 [GO] 2022―Mar―21 MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Dudley Benjamin Christie, Sarah Orfanos, Lorenzo Anez-Bustillos, et al. (+26)
161 [GO] 2022―Feb―16 COVID-19 and venous thromboembolism: A narrative review Dana E. Angelini, Scott Kaatz, Rachel P. Rosovsky, Rebecca L. Zon, Shreejith Pillai, William E. Robertson, et al. (+3)
162 [GO] 2022―Feb―08 Clinical relapse of immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination William Deucher, Senthil Sukumar, Spero R. Cataland
163 [GO] 2022―Jan―25 The ongoing enigma of SARS-CoV-2 and platelet interaction Younes Zaid, Fadila Guessous
164 [GO] 2022―Jan―15 Thromboelastography determined dynamics of blood coagulation and its correlation with complications and outcomes in patients with coronavirus disease 2019 Tushar Sehgal, Mukul Aggarwal, Upendra Baitha, Gaurav Gupta, Bindu Prakash, Anu Gupta, et al. (+3)
165 [GO] 2022―Jan―15 Vaccine-induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV-19 is rare in Asia Kochawan Boonyawat, Pantep Angchaisuksiri
166 [GO] 2021―Dec―17 Randomized trials of therapeutic heparin for COVID-19: A meta-analysis Michelle Sholzberg, Bruno R. Costa, Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, et al. (+13)
167 [GO] 2021―Nov―21 Safety of the second dose of the ChAdOx1 nCoV-19 vaccine in people with persistent anti-platelet factor 4 antibodies Noppacharn Uaprasert, Sasinipa Trithiphen, Autcharaporn Sukperm, Benjaporn Akkawat, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, et al. (+4)
168 [GO] 2021―Nov―03 The path of uncovering a prothrombotic thrombocytopenic syndrome after viral vector-based COVID-19 vaccination: Where there is much light, the shadow is deep Johannes Thaler, Cihan Ay, Paul Knoebl
169 [GO] 2021―Oct―16 Stability of vitamin K antagonist anticoagulation after COVID-19 diagnosis Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter
170 [GO] 2021―Oct―12 Prevalence of anti-platelet factor 4/polyanionic antibodies after COVID-19 vaccination with ChAdOx1 nCoV-19 and CoronaVac in Thais Phichchapha Noikongdee, Pornnapa Police, Tichayapa Phojanasenee, Pichika Chantrathammachart, Pimjai Niparuck, Teeraya Puavilai, et al. (+3)
171 [GO] 2021―Sep―25 Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge Anne-Marije Hulshof, Dionne C. W. Braeken, Chahinda Ghossein-Doha, Susanne van Santen, Jan-Willem E. M. Sels, Gerhardus J. A. J. M. Kuiper, et al. (+5)
172 [GO] 2021―Sep―18 Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people After ChAdOx1 nCoV-19 vaccination Noppacharn Uaprasert, Phandee Watanaboonyongcharoen, Rattaporn Vichitratchaneekorn, Sasinipa Trithiphen, Benjaporn Akkawat, Autcharaporn Sukperm, et al. (+4)
173 [GO] 2021―Sep―13 Severe COVID-19 is associated with endothelial activation and abnormal glycosylation of von Willebrand factor in patients undergoing hemodialysis Golzar Mobayen, Amrita Dhutia, Candice Clarke, Maria Prendecki, Stephen McAdoo, Renos Keniyopoullos, et al. (+4)
174 [GO] 2021―Aug―25 Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report Bader Al Rawahi, Hashem BaTaher, Zoheb Jaffer, Aya Al-Balushi, Asma Al-Mazrouqi, Noof Al-Balushi
175 [GO] 2021―Jun―28 Vascular thromboembolic events following COVID-19 hospital discharge: Incidence and risk factors Alex C. Spyropoulos, Dimitrios Giannis, Mark Goldin
176 [GO] 2021―May―19 Comparison of the coagulopathies associated with COVID-19 and sepsis Robert A. Campbell, Yohei Hisada, Frederik Denorme, Steven P. Grover, Emma G. Bouck, Elizabeth A. Middleton, et al. (+3)
177 [GO] 2021―May―08 Management of therapeutic unfractionated heparin in COVID-19 patients: A retrospective cohort study Lachelle D. Weeks, Katelyn W. Sylvester, Jean M. Connors, Nathan T. Connell
178 [GO] 2021―Mar―08 Caging the dragon: Research approach to COVID-19-related thrombosis Marieke J. H. A. Kruip, Suzanne C. Cannegieter, Hugo ten Cate, Eric C. M. Gorp, Nicole P. Juffermans, Frederikus A. Klok, et al. (+2)
179 [GO] 2021―Feb―24 Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19 Alex C. Spyropoulos, Stuart L. Cohen, Eugenia Gianos, Nina Kohn, Dimitrios Giannis, Saurav Chatterjee, et al. (+6)
180 [GO] 2021―Feb―18 Risk of thrombotic complications in influenza versus COVID-19 hospitalized patients MAM Stals, MJJH Grootenboers, C van Guldener, FHJ Kaptein, SJE Braken, Q Chen, et al. (+10)
181 [GO] 2021―Jan―15 Vascular thromboembolic events following COVID-19 hospital discharge: incidence and risk factors Harish Eswaran, Jamie A. Jarmul, Amy W. Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll
182 [GO] 2021―Jan―05 COVID-19-related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy Alice Assinger
183 [GO] 2020―Dec―07 Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality Fien A. Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundström, Ann-Sofie Rudberg, Maria Magnusson, et al. (+3)
184 [GO] 2020―Nov―10 eThrombosis: A new risk factor for venous thromboembolism in the pandemic era Daisuke Sueta, Koichi Kaikita, Kenichi Matsushita, Kenichi Tsujita
185 [GO] 2020―Oct―21 Harmonizing Hypercoagulable Heterogeneity: Baseline VTE Risk in COVID-19 George Goshua, Alfred Ian Lee
186 [GO] 2020―Sep―28 COVID-19 pandemic perspectives: A scientific silver lining? Dre'Von A. Dobson, Alisa S. Wolberg
187 [GO] 2020―Sep―25 Thrombo-inflammation response to Tocilizumab in COVID-19 Mansour Gergi, Mary Cushman, Benjamin Littenberg, Ralph C. Budd
188 [GO] 2020―Sep―25 Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis Stephan Nopp, Florian Moik, Bernd Jilma, Ingrid Pabinger, Cihan Ay
189 [GO] 2020―Sep―19 Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID-19 in Thai patients Nithita Nanthatanti, Sithakom Phusanti, Pichika Chantrathammachart, Kanin Thammavaranucupt, Pantep Angchaisuksiri, Somnuek Sungkanuparph
190 [GO] 2020―Jul―14 The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 Jori E. May, Rance C. Siniard, Marisa Marques
191 [GO] 2020―Jul―11 Thrombosis and coagulopathy in COVID-19: An illustrated review Marcel Levi, Beverley J. Hunt
192 [GO] 2020―Jul―09 Response to The challenges of diagnosing heparin-induced thrombocytopenia in patients with COVID-19 Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder
193 [GO] 2020―Jul―09 Anticoagulation Practice Patterns in COVID-19: A Global Survey Rachel P. Rosovsky, Kristen M Sanfilippo, Tzu Fei Wang, Sandeep K. Rajan, Surbhi Shah, Karlyn A. Martin, et al. (+8)
194 [GO] 2020―Jun―25 Staying updated on COVID-19: social media to amplify science in thrombosis and haemostasis Mike Makris
195 [GO] 2020―Jun―14 The underrecognized prothrombotic vascular disease of COVID-19 Kevin P. Cohoon, Guillaume Mahé, Alex C. Spyropoulos
196 [GO] 2020―Jun―08 Gender gap in women authors is not worse during COVID-19 pandemic: Results from Research and Practice in Thrombosis and Haemostasis Mary Cushman
197 [GO] 2020―May―29 Anticoagulation, Immortality, and Observations of COVID-19 Jason H. Maley, Camille R. Petri, Laura N. Brenner, Raghu R. Chivukula, Tiara F. Calhoun, Vladimir Vinarsky, C. Corey Hardin
198 [GO] 2020―May―29 Potential Role of Platelets in COVID-19: Implications for Thrombosis Milka Koupenova
199 [GO] 2020―May―21 STudy of Alteplase for Respiratory failure in SARS-Cov2/COVID-19: Study Design of the Phase IIa STARS Trial Hunter B. Moore, Christopher D. Barrett, Ernest E. Moore, Rashi Jhunjhnuwala, Robert C. McIntyre, Peter K Moore, et al. (+5)
200 [GO] 2020―May―20 Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 Adult Respiratory Distress Syndrome Richard R. Riker, Teresa L. May, Gilles L. Fraser, David J. Gagnon, Mahesh Bandara, Wes Zemrak, David B. Seder
201 [GO] 2020―May―20 Pulmonary embolism during the COVID-19 pandemic: decline in diagnostic procedures and incidence at a University Hospital Stephan Nopp, Karin Janata-Schwatczek, Helmut Prosch, Ihor Shulym, Oliver Königsbrügge, Ingrid Pabinger, Cihan Ay
202 [GO] 2020―May―14 Venous Thromboembolism in Critically Ill Patients with Covid-19: Results of a Screening Study for Deep Vein Thrombosis Alban Longchamp, Justine Longchamp, Sara Manzocchi-Besson, Livia Whiting, Claude Haller, Séverin Jeanneret, et al. (+16)
203 [GO] 2020―May―11 A Proposal for Staging COVID-19 Coagulopathy Jecko Thachil, Mary Cushman, Alok Srivastava
204 [GO] 2020―May―06 Thrombosis and Thromboembolism Related to COVID-19 A clarion call for obtaining solid estimates from large-scale multicenter data Stefano Barco, Stavros V Konstantinides
205 [GO] 2020―May―04 COVID-19 Hypothesis: Activated Protein C for Therapy of Virus-induced Pathologic Thromboinflammation John H. Griffin, Patrick Lyden
206 [GO] 2020―Apr―28 Fibrinolytic Therapy for Refractory COVID-19 Acute Respiratory Distress Syndrome: Scientific Rationale and Review Christopher D. Barrett, Hunter B. Moore, Ernest E. Moore, Robert C. McIntyre, Peter K Moore, John Burke, et al. (+7)
207 [GO] 2020―Apr―28 Emergence of Institutional Antithrombotic Protocols for Coronavirus 2019 Kevin P. Cohoon, Guillaume Mahé, Alfonso J. Tafur, Alex C. Spyropoulos
208 [GO] 2020―Apr―21 COVID-19 associated coagulopathy and thromboembolic disease: Commentary on an interim expert guidance Suzanne C Cannegieter, Frederikus A Klok
209 [GO] 2020―Apr―18 The Contact Activation System as a Potential Therapeutic Target in Patients with COVID-19 JJ Shatzel, EP DeLoughery, CU Lorentz, EI Tucker, JE Aslan, MT Hinds, et al. (+4)
 [1] 

209 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.018 sec